Clinicians can implant Hologic's LOCalizer tag inside a patient's breast up to 30 days before surgery and use a handheld reader to pinpoint the precise location of breast lesions prior to their removal. The LOCalizer device is designed to replace the traditional wire-guided method for localizing breast lesions, allowing for improved comfort and convenience for patients and clinicians, according to Hologic.

The LOCalizer wireless breast lesion localization device. Image courtesy of Hologic.

The device is on display at the Hologic booth at ECR 2019 in Vienna, along with the company's entire suite of breast and skeletal health products.

Hologic launches Unifi Analytics for mammography
Women's imaging firm Hologic has launched its Unifi Analytics, a web-based data analytics tool for managing mammography devices.

Hologic reports 5% revenue gain in Q1
Powered by double-digit growth in U.S. breast health, international, and global molecular diagnostics business, women's imaging firm Hologic saw revenue...

Hologic, Fujifilm settle mammography patent dispute
Hologic and Fujifilm Medical Systems USA have agreed to settle a dispute over patents relating to digital mammography technology, with the firms signing...

FDA clears Hologic's Localizer for long-term placement
The U.S. Food and Drug Administration (FDA) has cleared women's imaging firm Hologic's Localizer radiofrequency identification breast lesion localization...

Hologic looks forward to revenue growth in Q1
Women's imaging firm Hologic reported increases in revenue in its first-quarter preliminary results due to large growth in its molecular diagnostics,...